Why do some people not recommend long-term use of Tirzepatide?

Tirzepatide (Tirzepatide) is a new type of diabetes and weight loss drug that has attracted widespread attention for its excellent hypoglycemic and weight loss effects. However, despite its significant short-term efficacy, some medical experts and clinicians do not recommend long-term use of this drug for patients due to safety, tolerability, cost and potential dependence issues.

From a safety perspective, tilsiparatide is a dual receptor agonist for GLP-1 and GIP. Although its mechanism of action is advanced, its long-term effects are not yet fully understood. Some studies suggest the drug may increase the risk of gastrointestinal upset, pancreatitis and even thyroid tumors. In particular, the risk of thyroid C cell tumors observed in animal experiments has raised concerns about its long-term use, although this has not yet been confirmed in humans.

The issue of tolerance cannot be ignored either. Some patients perform well in the initial stage of taking the medicine, but as the time of use is prolonged, the body may gradually adapt to the medicine, resulting in a weakening of the effect. In addition, side effects such as nausea, vomiting, and loss of appetite may become more significant during long-term use, affecting quality of life.

The third is the financial burden. At present, the price of tilsiparatide is relatively high, especially in some countries, it has not been included in the scope of medical insurance reimbursement. Long-term use will cause greater financial pressure on patients and their families. At the same time, if the patient still needs to rely on the drug to maintain weight after achieving the weight loss goal, it will also cause concerns about drug dependence.

To sum up, although tilsiparatide is effective in treating diabetes and obesity, its long-term safety is still unclear and side effects may gradually appear. Coupled with the high cost of medication, many doctors tend to use it as a short-term intervention rather than long-term maintenance treatment. Therefore, when using this drug, patients should closely cooperate with their doctors to evaluate the risks and benefits, and avoid blind long-term use.

Reference materials:https://www.drugs.com/tirzepatide.html